Published Paper Details:

Oral delivery is a popular method in the pharmaceutical industry for its safety, convenience, cost-effectiveness, and high patient compliance. Angiotensin II receptor blockers (ARBs), like fimasartan, are used to treat hypertension by relaxing blood vessels and reducing blood pressure. Immediate release tablets are designed to disintegrate quickly, allowing for the swift release of active ingredients. These tablets are preferred due to their ease of self-administration, compactness, and simple manufacturing process. Formulation and evaluation of immediate-release tablets of Fimasartan were successful, demonstrating acceptable physicochemical properties and rapid drug release. These tablets offer convenience and efficacy for managing hypertension, but further studies, including stability testing and clinical trials, are needed to confirm their long-term stability, bioavailability, and clinical effectiveness before they can be introduced into the market and prescribed to patients